127 related articles for article (PubMed ID: 26434118)
21. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
22. Magnolol causes alterations in the cell cycle in androgen insensitive human prostate cancer cells in vitro by affecting expression of key cell cycle regulatory proteins.
McKeown BT; McDougall L; Catalli A; Hurta RA
Nutr Cancer; 2014; 66(7):1154-64. PubMed ID: 25264561
[TBL] [Abstract][Full Text] [Related]
23. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
Li Y; Mi C
Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
[TBL] [Abstract][Full Text] [Related]
24. Cytometry of cyclin proteins.
Darzynkiewicz Z; Gong J; Juan G; Ardelt B; Traganos F
Cytometry; 1996 Sep; 25(1):1-13. PubMed ID: 8875049
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
[TBL] [Abstract][Full Text] [Related]
26. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines.
Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
Cancer Res; 1994 Aug; 54(16):4285-8. PubMed ID: 8044772
[TBL] [Abstract][Full Text] [Related]
27. Korean Scutellaria baicalensis water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells.
Park KI; Park HS; Kang SR; Nagappan A; Lee DH; Kim JA; Han DY; Kim GS
J Ethnopharmacol; 2011 Jan; 133(2):634-41. PubMed ID: 21073943
[TBL] [Abstract][Full Text] [Related]
28. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
29. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
30. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
[TBL] [Abstract][Full Text] [Related]
31. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.
Rigolio R; Miloso M; Nicolini G; Villa D; Scuteri A; Simone M; Tredici G
Neurochem Int; 2005 Feb; 46(3):205-11. PubMed ID: 15670636
[TBL] [Abstract][Full Text] [Related]
33. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition.
Vidya Priyadarsini R; Senthil Murugan R; Maitreyi S; Ramalingam K; Karunagaran D; Nagini S
Eur J Pharmacol; 2010 Dec; 649(1-3):84-91. PubMed ID: 20858478
[TBL] [Abstract][Full Text] [Related]
34. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
35. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
Ferreira de Oliveira JMP; Pacheco AR; Coutinho L; Oliveira H; Pinho S; Almeida L; Fernandes E; Santos C
Arch Toxicol; 2018 Mar; 92(3):1205-1214. PubMed ID: 29270805
[TBL] [Abstract][Full Text] [Related]
36. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the contribution of changes in mRNA stability to the changes in steady-state levels of cyclin mRNA in the mammalian cell cycle.
Penelova A; Richman L; Neupert B; Simanis V; Kühn LC
FEBS J; 2005 Oct; 272(20):5217-29. PubMed ID: 16218953
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment.
Hasan AA; Kalinina E; Nuzhina J; Volodina Y; Shtil A; Tatarskiy V
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446140
[TBL] [Abstract][Full Text] [Related]
39. Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines.
Noordhuis P; Laan AC; van de Born K; Losekoot N; Kathmann I; Peters GJ
Biochem Pharmacol; 2008 Jul; 76(1):53-61. PubMed ID: 18508032
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
